Chinese
Japan
English
75 customized services results for
National Cancer Center Japan and ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development
ProLVV Manufacturing
One-stop AOC CMC Service
A Joint Collaboration Between Bio Immunitas and ProBio Leads to the Development and Fast Track Manufacturing of A Novel Therapeutic Platform
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program
Initium Therapeutics Strategically collaborates with ProBio
Host Cell Commercial License
ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program
ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII